meglumine has been researched along with Carcinoma, Hepatocellular in 87 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.15) | 18.7374 |
| 1990's | 19 (21.84) | 18.2507 |
| 2000's | 17 (19.54) | 29.6817 |
| 2010's | 40 (45.98) | 24.3611 |
| 2020's | 10 (11.49) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, D; Chen, X; Huang, H; Lin, X; She, D; Xiong, M; Zheng, W | 1 |
| Gao, W; Rao, SX; Song, D; Wang, M; Wang, W; Yang, C; Zeng, M; Zhu, K | 1 |
| Cai, S; Lin, N; Lin, X; Lin, Z; Sun, Y; Wang, X; Zhao, X | 1 |
| Ardito, F; Catalano, M; Cerrito, L; De Gaetano, AM; Giraldi, L; Giuliante, F; Gullì, C; Iezzi, R; Infante, A; Manfredi, R; Marini, MG; Marrone, G; Pompili, M; Ponziani, FR; Rapaccini, GL; Rodríguez Carnero, P; Vecchio, FM | 1 |
| Cauchy, F; De Vos, N; Rautou, PE; Ronot, M; Sartoris, R; Vilgrain, V | 1 |
| Luciani, A; Reizine, E | 1 |
| Amaddeo, G; Calderaro, J; Chalaye, J; Galletto Pregliasco, A; Itti, E; Kharrat, R; Kobeiter, H; Laurent, A; Legou, F; Luciani, A; Mulé, S; Regnault, H; Tacher, V; Tenenhaus, A | 1 |
| Bashir, MR; Erkanli, A; Gupta, RT; Marin, D; Nelson, RC; Shropshire, E; Wildman-Tobriner, B; Xiao, D; Zaki, IH; Zhang, S | 1 |
| Chen, J; He, B; Kuang, S; Rong, D; Tang, W; Wang, J; Xie, S; Zhang, L; Zhang, Y | 1 |
| Chen, F; Chen, S; Chen, Z; Deng, Y; He, B; Kuang, S; Liu, W; Luo, Q; Rong, D; Wang, J; Xie, Q; Xie, S; Yang, H; Zhang, Y | 1 |
| Bane, O; Cuevas, J; Cunha, GM; Fowler, KJ; Hectors, S; Kennedy, P; Lewis, S; Said, D; Sirlin, CB; Stocker, D; Taouli, B; Vietti-Violi, N | 1 |
| Adam, G; Bannas, P; Henes, FO; Rausch, VH; Well, L | 1 |
| Luciani, A; Pigneur, F; Roux, M | 1 |
| Braun, L; De Man, RA; De Vries, M; Dwarkasing, R; Gest, B; IJzermans, JN; Klompenhouwer, AJ; Thomeer, MG; van Beek, H | 1 |
| Beiderwellen, K; Deuschl, C; Forsting, M; Grüneisen, J; Herrmann, K; Heusch, P; Kirchner, J; Lauenstein, TC; Sawicki, LM; Umutlu, L | 1 |
| Allen, BC; Bashir, MR; Ho, LM; Jaffe, TA; Mazurowski, MA; Miller, CM | 1 |
| Amaddeo, G; Baranes, L; Calderaro, J; Laurent, A; Legou, F; Luciani, A; Mulé, S; Pigneur, F; Rahmouni, A; Reizine, E; Roche, V; Zegai, B | 1 |
| Adens-Fauquembergue, M; Azahaf, M; Behal, H; Ernst, O; Gnemmi, V; Lebert, P; Luciani, A | 1 |
| Ozkaya, G; Ozturk, K; Savci, G; Soylu, E; Yazici, Z | 1 |
| Buc, E; Da Ines, D; Fontarensky, M; Montoriol, PF; Petitcolin, V; Poincloux, L | 1 |
| Catalano, C; De Filippis, G; Di Martino, M; Di Miscio, R; Geiger, D; Lombardo, CV; Saba, L | 1 |
| Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E | 1 |
| Agnello, F; Brancatelli, G; Cabibbo, G; Furlan, A; Genco, C; Giannitrapani, L; Lagalla, R; Marin, D; Midiri, M; Salvaggio, G | 1 |
| Agarwal, S; Brunt, EM; Fowler, KJ; Menias, CO; Narra, VR; Shetty, AS | 1 |
| Besa, C; Cooper, N; Donnerhack, C; Dyvorne, H; Facciuto, M; Kakite, S; Taouli, B | 1 |
| Koh, DM; Riddell, AM; Thian, YL | 1 |
| Choi, D; Jeong, WK; Kim, YK; Lim, HK; Song, KD | 1 |
| Al-Hawary, MM; Davenport, MS; Glazer, DI; Hussain, HK; Kaza, RK; Khalatbari, S; Liu, PS; Maturen, KE; Patel, J; Somashekar, DK; Stein, EB; Viglianti, BL; Wasnik, AP | 1 |
| Kim, JH; Kim, KW; Kim, SY; Lee, MG; Lee, SJ; Shin, YM; You, MW | 1 |
| Cho, ES; Kim, DJ; Kim, KA; Lee, EJ | 1 |
| Bolondi, L; Colombo, M; Forzenigo, LV; Galassi, M; Golfieri, R; Granito, A; Iavarone, M; Piscaglia, F; Renzulli, M; Salvatore, V; Sangiovanni, A; Vavassori, S | 1 |
| Caruso, S; Cortis, K; Liotta, R; Luca, A; Miraglia, R; Tuzzolino, F | 1 |
| Brancatelli, G; Cabibbo, G; Dioguardi Burgio, M; Lagalla, R; Midiri, M; Picone, D | 1 |
| Barth, BK; Becker, A; Donati, OF; Fischer, MA; Karlo, CA; Reiner, CS; Seifert, B; Ulbrich, EJ | 1 |
| Cameron, AL; Duncan, JK; Ma, N; Maddern, G; Vreugdenburg, TD | 1 |
| Choi, BI; Choi, SH; Jang, JJ; Kim, SH; Lee, JM; Suh, KS; Yu, NC | 1 |
| Abdullah, SS; Bancel, B; Baulieux, J; Berthezene, Y; Duboeuf, F; Ducerf, C; Mabrut, JY; Pialat, JB; Rode, A; Wiart, M | 1 |
| Fan, J; Fan, M; Jiang, GL; Wang, J; Xie, LY; Xu, XL | 1 |
| Catalano, C; De Filippis, G; Di Martino, M; Ginanni Corradini, S; Guerrisi, A; Marin, D; Masciangelo, R; Passariello, R; Rossi, M | 1 |
| Jeon, TY; Kim, SH; Lee, WJ; Lim, HK | 1 |
| Bielen, D; De Keyzer, F; Dymarkowski, S; Komuta, M; Nevens, F; Op de Beeck, K; Roebben, I; Roskams, T; Topal, B; Vandecaveye, V; Verslype, C | 1 |
| Choi, BI; Han, JK; Kim, SH; Kim, SJ; Lee, JM; Lee, JY; Yoo, HJ | 1 |
| Brubaker, LM; Elazzazi, M; Hayashi, P; Kierans, AS; Leonardou, P; Semelka, RC; Shaikh, F | 1 |
| Gamst, A; Hanna, RF; Kased, N; Malek, P; Mwangi, I; Shiehmorteza, M; Sirlin, C; Wolfson, T | 1 |
| Pastor, CM | 1 |
| Wiwanitkit, V | 1 |
| Fidler, J; Hough, D | 1 |
| Haider, MA; Jacks, LM; Jang, HJ; Khalili, K; Kim, TK; Lee, KH; Menezes, RJ; Park, SH; Sherman, M; Yazdi, L | 1 |
| Akisik, FM; Bertrand, K; Mhapsekar, R; Ramaswamy, R; Sandrasegaran, K; Saxena, R; Tahir, B | 1 |
| Brown, JJ; Fowler, KJ; Narra, VR | 1 |
| Adsay, NV; Becker-Weidman, DJ; Chen, Z; Farris, AB; Hanish, SI; Kalb, B; Kitajima, HD; Knechtle, SJ; Lurie, CR; Martin, DR; Sharma, P; Spivey, JR | 1 |
| Bova, V; Luca, A; Maruzzelli, L; Miraglia, R; Vizzini, GB | 1 |
| Bonomo, L; Ciresa, M; De Gaetano, AM; Gasbarrini, A; Gatto, A; Giuga, M; Giuliante, F; Miele, L; Pizzolante, F; Pompili, M; Rapaccini, GL; Riccardi, L; Siciliani, L; Vecchio, FM | 1 |
| de Campos, RO; Hernandes, M; Kim, BS; Kim, HJ; Kim, MJ; Kim, SH; Semelka, RC | 1 |
| Angileri, R; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E; Ukmar, M | 1 |
| Angthong, W; Hayashi, PH; Kim, BS; Kim, SH; Semelka, RC; Srirattanapong, S; Woosley, JT | 1 |
| Kim, CS; Kim, YK; Lee, JM | 1 |
| Kim, CS; Kim, YK; Kwak, HS; Lee, JM; Lee, YH | 1 |
| Kim, CS; Kim, YK; Kwak, HS; Lee, JM | 1 |
| Ouyang, H; Zhang, HM; Zhou, CW | 1 |
| Han, YM; Kim, CS; Kim, YK; Lee, YH | 1 |
| Beaty, SD; Depetris, G; Silva, AC | 1 |
| Ida, M; Inoue, K; Itoh, H; Kadoya, M; Matsui, O; Suzuki, M; Takashima, T | 1 |
| Shimatani, Y; Suto, Y | 1 |
| Casillas, C; Ferrer, MD; Martí-Bonmatí, L; Masiá, L; Torrijo, C | 1 |
| Arita, T; Choji, T; Fujita, T; Honjo, K; Ito, K; Matsumoto, T; Nakanishi, T | 1 |
| Bartolozzi, C; Caramella, D; Ciancia, EM; Lencioni, R; Mazzeo, S | 1 |
| Dabatin, JF; Francis, IR; Glazer, GM; Herfkens, RJ; Jeffrey, RB; Li, KC; Low, RN; McDonnell, CH; Van Dalsem, WJ; Whitney, WS | 1 |
| Hori, S; Kozuka, T; Mitani, T; Monden, M; Murakami, T; Nakamura, H; Nakanishi, K; Tomoda, K; Tsuda, K; Wakasa, K | 1 |
| Foo, TK; Francis, IR; Glazer, GM; Herfkens, RJ; Jeffrey, RB; Low, RN; Pelc, NJ; Shimakawa, A | 1 |
| Andoh, K; Itoh, Y; Kinno, Y; Odagiri, K; Tarao, K | 1 |
| Hirohashi, S; Kadoya, M; Katayama, H; Kuwatsuru, R; Tanimoto, A | 1 |
| Baron, RL; Murakami, T; Peterson, MS | 1 |
| Atilla, S; Borrello, JA; Brown, JJ; Pilgram, TK; Quillin, SP; Yu, CY | 1 |
| Diebold, T; Felix, R; Hammerstingl, R; Lodemann, KP; Mack, M; Neuhaus, P; Pegios, W; Stupavsky, A; Vogl, TJ | 1 |
| Itai, Y | 1 |
| Baron, RL; Cotroneo, AR; De Franco, A; De Gaetano, AM; Manfredi, R; Marano, P; Maresca, G; Pirovano, G; Spinazzi, A | 1 |
| Hiramatsu, K; Hirohashi, S; Kadoya, M; Katayama, H; Kuwatsuru, R; Murakami, T; Ohtomo, K; Tanimoto, A; Yoshikawa, K | 1 |
| Hamm, B; Kirchin, M; Pirovano, G; Spinazzi, A | 1 |
| Grazioli, L; Kirchin, M; Pirovano, G; Spinazzi, A | 1 |
| Hirohashi, S; Kadoya, M; Katayama, H; Kuwatsuru, R; Murakami, T; Ohtomo, K; Tanaka, Y; Tanimoto, A; Yoshikawa, K | 2 |
| Bartolozzi, C; Spinazzi, A | 1 |
| Benetti, A; Caudana, R; Colombari, R; Grazioli, L; Kirchin, MA; Morana, G; Pirovano, G; Portolani, N; Spinazzi, A; Talamini, G | 1 |
| Arneson, V; Daldrup-Link, HE; Grazioli, L; Greco, A; Hamm, B; Holzknecht, N; Imperatori, L; Kirchin, MA; Manfredi, R; Marti-Bonmati, L; Pirovano, G; Rummeny, E; Spinazzi, A; Vanzulli, A | 1 |
| Katayama, H; Kuwatsuru, R | 1 |
| Kirchin, MA; Spinazzi, A | 1 |
7 review(s) available for meglumine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Liver-specific agents for contrast-enhanced MRI: role in oncological imaging.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Gadolinium DTPA; Hemangioma; Humans; Image Enhancement; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2013 |
The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.
Topics: Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Hemangioma; Humans; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Radiography | 2013 |
Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Prevalence; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Utilization Review | 2017 |
Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diffusion Magnetic Resonance Imaging; Focal Nodular Hyperplasia; Gadolinium DTPA; Hemangioma; Hepatocytes; Humans; Incidental Findings; Liver; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2011 |
Clinical utility and safety of MultiHance in magnetic resonance imaging of liver cancer: results of multicenter studies in Europe and the USA.
Topics: Carcinoma, Hepatocellular; Clinical Trials as Topic; Contrast Media; Europe; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Multicenter Studies as Topic; Organometallic Compounds; Safety; United States | 1999 |
MultiHance: help or hype?
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 1999 |
[Hepatocyte targeted MR contrast agent--Gd-BOPTA(E-7155)].
Topics: Animals; Carcinoma, Hepatocellular; Clinical Trials as Topic; Contrast Media; Diagnosis, Differential; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2001 |
9 trial(s) available for meglumine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Three-dimensional dynamic liver MR imaging using sensitivity encoding for detection of hepatocellular carcinomas: comparison with superparamagnetic iron oxide-enhanced mr imaging.
Topics: Carcinoma, Hepatocellular; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Humans; Image Enhancement; Imaging, Three-Dimensional; Iron; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Oxides; Predictive Value of Tests; ROC Curve; Sensitivity and Specificity | 2004 |
[Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2006 |
[Early phase II trial of Gd-BOPTA (E7155) for the MR imaging of liver tumors].
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 1996 |
Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation.
Topics: Carcinoma, Hepatocellular; Contrast Media; Double-Blind Method; Female; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Time Factors | 1997 |
Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA).
Topics: Aged; Carcinoma, Hepatocellular; Female; Gadolinium; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds | 1999 |
MultiHance in the dynamic phase of contrast enhancement: a pictorial assessment.
Topics: Adenoma; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Focal Nodular Hyperplasia; Gadolinium; Hemangioma; Humans; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Prospective Studies | 1999 |
Clinical late phase II trials of MultiHance (Gd-BOPTA) for the magnetic resonance imaging of liver tumors in Japan.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Humans; Japan; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Safety | 1999 |
Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2001 |
Low-dose gadobenate dimeglumine-enhanced MRI in the detection and characterization of focal liver lesions.
Topics: Carcinoma, Hepatocellular; Contrast Media; Hemangioma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Sensitivity and Specificity | 2002 |
71 other study(ies) available for meglumine and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2022 |
A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies | 2022 |
Quantitative parameters obtained from gadobenate dimeglumine-enhanced MRI at the hepatobiliary phase can predict post-hepatectomy liver failure and overall survival in patients with hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Hepatectomy; Humans; Liver Failure; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2022 |
Critical analysis of major and ancillary features of LI-RADS v2018 in the differentiation of small (≤ 2 cm) hepatocellular carcinoma from dysplastic nodules with gadobenate dimeglumine-enhanced magnetic resonance imaging.
Topics: Aged; Carcinoma, Hepatocellular; Cell Differentiation; Consensus; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Radiologists; Radionuclide Imaging; Retrospective Studies; Sensitivity and Specificity | 2019 |
Performance of liver surface nodularity quantification for the diagnosis of portal hypertension in patients with cirrhosis: comparison between MRI with hepatobiliary phase sequences and CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed | 2020 |
Reply to "Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia".
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Contrast Media; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2020 |
Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Choline; Contrast Media; Disease-Free Survival; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies | 2020 |
How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?
Topics: Aged; Carcinoma, Hepatocellular; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2021 |
The role of lesion hypointensity on gadobenate dimeglumine-enhanced hepatobiliary phase MRI as an additional major imaging feature for HCC classification using LI-RADS v2018 criteria.
Topics: Carcinoma, Hepatocellular; Contrast Media; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2021 |
Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2021 |
Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Perfusion; Prospective Studies | 2021 |
Transient Severe Motion Artifact Related to Gadoxetate Disodium-Enhanced Liver MRI: Frequency and Risk Evaluation at a German Institution.
Topics: Adult; Aged; Aged, 80 and over; Artifacts; Ascites; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Germany; Humans; Infusions, Intravenous; Liver; Liver Cirrhosis; Liver Neoplasms; Lung Diseases; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pleural Effusion; Risk Factors; Young Adult | 2017 |
Response to "Quantitative analysis of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of llcer method using gadobenate dimeglumine as contrast agent".
Topics: Carcinoma, Hepatocellular; Contrast Media; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Meglumine; Organometallic Compounds | 2018 |
Quantitative analysis Of hepatocellular adenoma and focal nodular hyperplasia in the hepatobiliary phase: External validation of LLCER method using gadobenate dimeglumine as contrast agent.
Topics: Carcinoma, Hepatocellular; Contrast Media; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 2018 |
18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Melanoma; Middle Aged; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity | 2017 |
Comparison of Visualization Rates of LI-RADS Version 2014 Major Features With IV Gadobenate Dimeglumine or Gadoxetate Disodium in Patients at Risk for Hepatocellular Carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2018 |
Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Topics: Adenoma, Liver Cell; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organic Anion Transporters; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2018 |
MRI for characterization of benign hepatocellular tumors on hepatobiliary phase: the added value of in-phase imaging and lesion-to-liver visual signal intensity ratio.
Topics: Adenoma, Liver Cell; Adult; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Fatty Liver; Female; Focal Nodular Hyperplasia; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity; Young Adult | 2019 |
Differentiation of hepatocellular carcinoma from non-hepatocellular malignant tumours of liver by chemical-shift MRI at 3 T.
Topics: Adipose Tissue; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2019 |
Advantages of gadobenate dimeglumine-enhanced MR cholangiography in the diagnosis of post-liver transplant bile leakage.
Topics: Adult; Anastomotic Leak; Bile; Bile Duct Diseases; Carcinoma, Hepatocellular; Cholangiography; Cholangiopancreatography, Magnetic Resonance; Contrast Media; Female; Hepatitis C, Chronic; Humans; Image Enhancement; Liver Cirrhosis, Alcoholic; Liver Neoplasms; Liver Transplantation; Male; Meglumine; Middle Aged; Organometallic Compounds; Postoperative Complications | 2013 |
Detection of small (≤2 cm) HCC in cirrhotic patients: added value of diffusion MR-imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Liver Cirrhosis; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Sensitivity and Specificity | 2013 |
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Image Interpretation, Computer-Assisted; Iohexol; Iopamidol; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Phospholipids; Reproducibility of Results; Retrospective Studies; Subtraction Technique; Sulfur Hexafluoride; Tomography, X-Ray Computed; Ultrasonography | 2013 |
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iopamidol; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Niacinamide; Organometallic Compounds; Phenylurea Compounds; Sorafenib; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Gadolinium DTPA; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Phenotype; Risk Factors; Tomography, X-Ray Computed | 2014 |
Hepatocellular carcinoma: short-term reproducibility of apparent diffusion coefficient and intravoxel incoherent motion parameters at 3.0T.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Echo-Planar Imaging; Gadolinium DTPA; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Neoplasms; Male; Meglumine; Middle Aged; Motion; Observer Variation; Organometallic Compounds; Prospective Studies; Reproducibility of Results | 2015 |
Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Clinical Competence; Contrast Media; Female; Humans; Imaging, Three-Dimensional; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies | 2014 |
Recent advances in the imaging of hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Contrast Media; Ferric Compounds; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Oxides; Tomography, X-Ray Computed; Ultrasonography | 2015 |
Effect of increasing the flip angle during the hepatocyte phase of gadobenate dimeglumine-enhanced 1.5T MRI in cirrhotic patients with hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatocytes; Humans; Image Enhancement; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Radiology; Retrospective Studies; Signal-To-Noise Ratio | 2016 |
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging.
Topics: Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Female; Gadolinium DTPA; Hepatocytes; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2015 |
Incorporating the hepatobiliary phase of gadobenate dimeglumine-enhanced MRI in the diagnosis of hepatocellular carcinoma: increasing the sensitivity without compromising specificity.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2016 |
MR-imaging features of hepatocellular carcinoma capsule appearance in cirrhotic liver: comparison of gadoxetic acid and gadobenate dimeglumine.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Retrospective Studies; Sensitivity and Specificity | 2016 |
Reliability, Validity, and Reader Acceptance of LI-RADS-An In-depth Analysis.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Observer Variation; Organometallic Compounds; Radiology Information Systems; Reproducibility of Results; Retrospective Studies; ROC Curve | 2016 |
Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2008 |
Characterization of hepatocellular carcinoma and colorectal liver metastasis by means of perfusion MRI.
Topics: Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast Media; Female; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Statistics, Nonparametric | 2008 |
Metastatic hepatocellular carcinoma in the esophagus following liver transplantation.
Topics: Carcinoma, Hepatocellular; Contrast Media; Esophageal Neoplasms; Female; Humans; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Predictive Value of Tests; Sensitivity and Specificity | 2008 |
Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
The value of gadobenate dimeglumine-enhanced hepatobiliary-phase MR imaging for the differentiation of scirrhous hepatocellular carcinoma and cholangiocarcinoma with or without hepatocellular carcinoma.
Topics: Adult; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2010 |
Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma.
Topics: Algorithms; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Cirrhosis; Liver Neoplasms; Meglumine; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2009 |
Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Enhancement; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2009 |
MRI findings of rapidly progressive hepatocellular carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2010 |
Apparent diffusion coefficient of fibrosis and regenerative nodules in the cirrhotic liver at MRI.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Humans; Image Interpretation, Computer-Assisted; Liver Cirrhosis; Liver Neoplasms; Liver Regeneration; Male; Meglumine; Middle Aged; Organometallic Compounds; Prospective Studies; Regression Analysis | 2010 |
Gadoxetic acid-enhanced hepatobiliary phase MR imaging: cellular insight.
Topics: Animals; Carcinoma, Hepatocellular; Contrast Media; Gadolinium DTPA; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Rats | 2010 |
MRI findings of hepatocellular carcinoma.
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Sensitivity and Specificity | 2011 |
Hepatocyte-specific magnetic resonance imaging contrast agents.
Topics: Adenoma, Liver Cell; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Hepatocytes; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Middle Aged; Organometallic Compounds | 2011 |
Analysis of gadobenate dimeglumine-enhanced MR findings for characterizing small (1-2-cm) hepatic nodules in patients at high risk for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Population Surveillance; Practice Guidelines as Topic; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2011 |
Does the hepatocellular phase of gadobenate dimeglumine help to differentiate hepatocellular carcinoma in cirrhotic patients according to histological grade?
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Liver Cirrhosis; Liver Neoplasms; Logistic Models; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; ROC Curve | 2011 |
Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging--comparison to prior same-center results after MR systems improvements.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2011 |
Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies.
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Contrast Media; Embolization, Therapeutic; Female; Humans; Iohexol; Liver Neoplasms; Liver Transplantation; Logistic Models; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Predictive Value of Tests; Treatment Outcome; Triiodobenzoic Acids | 2013 |
Differentiating hepatocellular carcinoma from dysplastic nodules at gadobenate dimeglumine-enhanced hepatobiliary-phase magnetic resonance imaging.
Topics: Aged; Biopsy, Large-Core Needle; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 2013 |
Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient.
Topics: Adenoma, Liver Cell; Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Focal Nodular Hyperplasia; Gadolinium DTPA; Hemangioma; Hepatic Artery; Hepatocytes; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Liver Transplantation; Magnetic Resonance Imaging; Male; Mass Screening; Meglumine; Middle Aged; Organometallic Compounds; Pancreas; Retrospective Studies; Sensitivity and Specificity | 2013 |
Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Topics: Aged; Aged, 80 and over; Arteries; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Contrast Media; Female; Focal Nodular Hyperplasia; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Prospective Studies | 2013 |
Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging.
Topics: Adult; Aged; alpha-Fetoproteins; Analysis of Variance; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity | 2013 |
Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Neoplasm Staging; Organometallic Compounds; Probability; Prospective Studies; Sampling Studies; Sensitivity and Specificity | 2004 |
Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Dextrans; Female; Ferrosoferric Oxide; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Meglumine; Middle Aged; Organometallic Compounds; Oxides; Predictive Value of Tests; Radionuclide Imaging | 2004 |
Added diagnostic value of T2-weighted MR imaging to gadolinium-enhanced three-dimensional dynamic MR imaging for the detection of small hepatocellular carcinomas.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Predictive Value of Tests; Retrospective Studies; ROC Curve; Sensitivity and Specificity | 2008 |
AJR teaching file: incidental hepatic mass.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Hepatitis C, Chronic; Humans; Incidental Findings; Liver Failure; Liver Neoplasms; Lymphoma; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Tomography, X-Ray Computed | 2008 |
Work in progress: dynamic sequential computed tomography during arterial portography in the detection of hepatic neoplasms.
Topics: Angiography; Carcinoma, Hepatocellular; Hepatic Artery; Humans; Liver Neoplasms; Meglumine; Portography; Tomography, X-Ray Computed | 1983 |
Dual contrast magnetic resonance imaging with combined use of positive and negative contrast agent in human hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Chondroitin Sulfates; Colloids; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Iron; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1995 |
Dynamic MR imaging of liver tumors: analysis with temporal reconstruction images.
Topics: Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Hemangioma; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Retrospective Studies; Time Factors | 1994 |
Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
Topics: Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Radiography | 1994 |
Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Ethanol; Female; Follow-Up Studies; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Organometallic Compounds; Pentetic Acid; Time Factors | 1994 |
Dynamic breath-hold multiplanar spoiled gradient-recalled MR imaging with gadolinium enhancement for differentiating hepatic hemangiomas from malignancies at 1.5 T.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Hemangioma; Heterocyclic Compounds; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity | 1993 |
Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
Topics: Aged; Carcinoma, Hepatocellular; Drug Combinations; Embolization, Therapeutic; Female; Gadolinium DTPA; Humans; Iodized Oil; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Gadolinium DTPA; Humans; Image Enhancement; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid | 1993 |
Gadopentetate dimeglumine as an alternative contrast material for use in angiography.
Topics: Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Embolization, Therapeutic; Gadolinium; Gadolinium DTPA; Hepatic Artery; Humans; Liver Neoplasms; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Rupture, Spontaneous | 1993 |
Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Drug Combinations; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Prospective Studies; Retrospective Studies | 1996 |
Characterization of focal hepatic masses by dynamic contrast-enhanced MR imaging: findings in 311 lesions.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Cysts; Drug Combinations; Female; Follow-Up Studies; Gadolinium; Gadolinium DTPA; Hemangioma, Cavernous; Hepatic Artery; Humans; Image Enhancement; Injections, Intra-Arterial; Injections, Intravenous; Liver Diseases; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Pentetic Acid; Respiration; Retrospective Studies; Sensitivity and Specificity; Single-Blind Method | 1997 |
Capsule of hepatocellular carcinoma: where and how does the capsule show enhancement?
Topics: Carcinoma, Hepatocellular; Contrast Media; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds | 1999 |
Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: results from phase II and phase III clinical trials in Japan.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Contrast Media; Female; Humans; Image Processing, Computer-Assisted; Injections, Intravenous; Japan; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Multicenter Studies as Topic; Organometallic Compounds | 1999 |
Hepatocellular carcinoma: correlation between gadobenate dimeglumine-enhanced MRI and pathologic findings.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies; Time Factors | 2000 |
Evaluation of the accuracy of gadobenate dimeglumine-enhanced MR imaging in the detection and characterization of focal liver lesions.
Topics: Adult; Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Image Enhancement; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Retrospective Studies | 2000 |